You don't, because they are trolls. You can't possibly argue in good faith that being able to provide less than 0.1% of novel treatments is somehow more valuab

You don't, because they are trolls. You can't possibly argue in good faith that being able to provide less than 0.1% of novel treatments is somehow more valuable than providing good, standard healthcare with already existing drugs and treatment protocols to the other 99.9% at a sane cost.